Published: 14 May 2019
Author(s): Dana Kigitovica, Matiss Sablinskis, Kristaps Sablinskis, Ainars Rudzitis, Andris Skride
Issue: May 2019
Section: Letter to the Editor

Pulmonary hypertension (PH) is a heterogeneous group of disorders that can be classified according to clinical, hemodynamic and pathological findings and the prognosis of each group differs substantially [1]. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are distinct types of pre-capillary PH, defined by mean pulmonary arterial pressure (mPAP) >20 mmHg, pulmonary arterial wedge pressure (PAWP) ≤15 mmHg and PVR ≥ 3 Wood units [2].

Newsletters

Stay informed on our latest news!